Percutaneous renal surgery in children with complex stones.
OBJECTIVE
We report our experience with percutaneous nephrolithotomy (PNL) therapy for staghorn or complex pediatric renal calculi.


METHODS
We retrospectively analyzed the case records of 105 patients younger than 17 years who underwent PNL. The cases included 53 complex calculi analyzed in 51 patients. We defined complex calculi as either staghorn or those with a stone bulk larger than 300 mm(2), involving more than one calix, the upper ureter or stone in anomalous kidney.


RESULTS
Mean age of patients with complex calculi was 9.7+/-0.7 years and stone burden was 654+/-92.4mm(2). The median duration of PNL was 90+/-4.7 (30-220) min. Complete clearance was achieved in 39 patients (73.6%). Of these, 32 (60.4%) required a single tract, while 21 (39.6%) required multiple tracts. With subsequent shock wave lithotripsy and PNL, the clearance rate increased to 86.8%. The average hemoglobin drop was 1.6+/-0.16 g/dL. Assessing the factors affecting the hemoglobin drop, the number of tracts (P=0.01) and size of tracts (P=0.002) were found to be significant. The mean change in serum creatinine concentration between preoperative and postoperative measurements was -0.01+/-0.02 mg/dL, for both patients with a single tract and those with multiple tracts.


CONCLUSIONS
PNL is safe and effective in the management of staghorn and complex renal calculi in children. Tract dilatation and number of tracts are important factors in reducing blood loss.
Ozden
Ender
E
Department of Urology, Hacettepe University, Ankara, Turkey.
Sahin
Ahmet
A
Tan
Bekir
B
Doğan
Hasan Serkan
HS
Eren
Murat Tugrul
MT
Tekgül
Serdar
S
D016063:Blood Loss, Surgical; D002648:Child; D005260:Female; D006454:Hemoglobins; D006801:Humans; D007668:Kidney / Q000002:abnormalities / Q000601:surgery; D008297:Male; D009403:Nephrostomy, Percutaneous; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014513:Ureter / Q000601:surgery; D014545:Urinary Calculi / Q000601:surgery*
D006454:Hemoglobins